Please login to the form below

Not currently logged in

Ogilvy & Mather and CommonHealth to merge

Two of WPP's healthcare marketing networks, Ogilvy & Mather and CommonHealth are to merge to form Ogilvy CommonHealth Worldwide

Two of WPP's healthcare marketing networks, Ogilvy & Mather and CommonHealth are to merge to form Ogilvy CommonHealth Worldwide.

The new group will have more than 1,100 employees in 33 countries. Its offerings will include professional and consumer advertising and promotion, relationship marketing, digital/interactive services, media planning and buying, public affairs and relations, managed care marketing, medical education, clinical trial recruitment, market research and analytics and strategic consulting.

CommonHealth's president and CEO Matt Giegerich will become chairman and CEO of the new organisation. He said: "By combining our two organisations – and the remarkable collective talent pool within – we can offer clients all the communications resources necessary to create and grow powerful, unified global brands in a rapidly evolving healthcare environment."

The group will operate under the Ogilvy CommonHealth Worldwide umbrella, but maintain individual Ogilvy CommonHealth and Ogilvy Healthworld brand identities in some markets. An executive council, comprised of leadership from both organisations, will oversee daily operations.

28th June 2010


Featured jobs

Subscribe to our email news alerts


Add my company

We are a specialist strategy consulting firm for pharmaceutical and biotech companies. We help our clients to achieve significant performance...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...